patent/CN-104321071-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104321071-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1013
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0823 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10
filingDate	2012-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf64ba3731b69623f100ccb466354cbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88074c22137b3560101571233207be3d
publicationDate	2015-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-104321071-A
titleOfInvention	NMDA receptor modulators and uses thereof
abstract	The present invention discloses compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for the treatment of diseases and conditions such as learning, cognitive activity and analgesia, in particular for the alleviation and/or reduction of neuropathic pain. Oral formulations and other pharmaceutically acceptable delivery forms including intravenous formulations of the compounds are also disclosed.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9512134-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932347-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9512133-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196401-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11028095-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441572-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10253032-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077094-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925169-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376250-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110003309-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10906913-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10052308-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758525-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9802946-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578072-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108148113-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828384-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512051-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427585-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441571-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11370790-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10273239-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530223-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9708335-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150769-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961189-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104109189-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110003309-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104109189-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10918637-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9579304-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9738650-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11299495-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10316041-B2
priorityDate	2011-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007027559-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-3318622-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2371375-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6902886-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005176649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011044089-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6897028-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4683221-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010033757-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468104222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467342994

Total number of triples: 78.